search
Back to results

A New Method of Surgically Treating Varicose Veins and Venous Ulcers - a Study to Assess Clinical and Economic Value

Primary Purpose

Varicose Veins, Venous Insufficiency, Venous Ulceration

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Surgery - Saphenofemoral ligation, saphenous strip and avulsions
EVLT
Sponsored by
Hull University Teaching Hospitals NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Varicose Veins focused on measuring Varicose veins, Chronic venous insufficiency, Venous ulceration, Surgery, Endovenous Laser

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Primary, symptomatic, varicose veins.
  • Isolated Saphenofemoral junction (SFJ) incompetence leading to long saphenous (LSV) reflux on duplex ultrasound.
  • LSV of 4mm diameter at the knee.
  • Ability to give informed written consent.

Exclusion Criteria:

  • Inability to give informed written consent.
  • Symptomatic or complicated varicose veins not attributable to SFJ/LSV reflux.
  • Evidence of deep venous reflux on duplex scan.

Sites / Locations

  • Hull Royal Infirmary

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Surgery

EVLT

Arm Description

Outcomes

Primary Outcome Measures

Generic Quality of life - Short Form-36

Secondary Outcome Measures

Disease Specific quality of life - Aberdeen Varicose Vein Questionnaire
Generic quality of life - EuroQol
Venous Clinical Severity Score
Visual analogue pain scores
Return to work and normal functioning
Would undergo EVLT again if necessary
Complication rates
Duplex and clinical assessment
A detailed clinical and duplex ultrasound assessment was undertaken to identify: The presence of residual or recurrent varicose veins (defined as clinically evident varicose veins of greater than 3mm in diameter present at 1 and 6 weeks (residual) or becoming evident only after 6 weeks (recurrent). This was irrespective of the presence or absence of symptoms. The pattern of underlying insufficiency on duplex giving rise to any clinically evident varicose veins or skin changes.
Cost Effectiveness

Full Information

First Posted
September 23, 2008
Last Updated
August 17, 2022
Sponsor
Hull University Teaching Hospitals NHS Trust
Collaborators
University of Hull
search

1. Study Identification

Unique Protocol Identification Number
NCT00759434
Brief Title
A New Method of Surgically Treating Varicose Veins and Venous Ulcers - a Study to Assess Clinical and Economic Value
Official Title
A Dual Centre, Randomised Controlled Trial of the Clinical and Cost Effectiveness of Endovenous Laser Therapy (EVLT) in the Treatment of Varicose Veins and Venous Ulcers
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
March 2004 (Actual)
Primary Completion Date
August 2009 (Actual)
Study Completion Date
August 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hull University Teaching Hospitals NHS Trust
Collaborators
University of Hull

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Varicose veins are a common problem, affecting up to a third of the western adult population. Most suffer with aching, discomfort, pruritis, and muscle cramps, whilst complications include oedema, eczema, lipodermatosclerosis, ulceration, phlebitis, and bleeding. This is known to have a significant negative effect on patient's quality of life (QoL). Surgery has been used for many years, but it is known that there is a temporary decline in QoL post-op. This was demonstrated in our pilot study. Surgery leads to painful and prolonged recovery in some patients and has the risks of infection, haematoma and nerve injury. Recurrence rates are known to be significant. Duplex of veins post surgery has demonstrated persistent reflux in 9-29% of cases at 1 year, 13-40% at 2 years, 40% at 5 years and 60% at 34 years. 26% of NHS patients were 'very dissatisfied' with their varicose vein surgery. Newer, less invasive treatments are being developed. It would be advantageous to find a treatment that avoided the morbidity of surgery, one that could be performed as a day-case procedure under a local anaesthetic, a treatment that could offer lower recurrence rates and allow an early return to work. These should be the aims of any new treatment for varicose veins. Endovenous Laser Treatment (EVLT) is performed under a local anaesthetic and uses laser energy delivered into the vein to obliterate it. The vein therefore need not be tied off surgically and stripped out. The aim of this study is to compare the clinical, cost effectiveness and safety of Surgery and EVLT.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Varicose Veins, Venous Insufficiency, Venous Ulceration
Keywords
Varicose veins, Chronic venous insufficiency, Venous ulceration, Surgery, Endovenous Laser

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
280 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Surgery
Arm Type
Active Comparator
Arm Title
EVLT
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Surgery - Saphenofemoral ligation, saphenous strip and avulsions
Intervention Description
Patients undergo Saphenofemoral ligation, inversion stripping of the Long Saphenous Vein and avulsion of varicosities if necessary under a general anaesthetic.
Intervention Type
Procedure
Intervention Name(s)
EVLT
Intervention Description
Patients undergo endovenous laser treatment, using a 810nm laser aiming to occlude the incompetent long saphenous vein from the saphenofemoral junction to the knee. This may then be followed by ambulatory phlebectomy as appropriate. All procedures are to be performed under a local anaesthetic.
Primary Outcome Measure Information:
Title
Generic Quality of life - Short Form-36
Time Frame
1 week, 6 weeks, 3 months, 1 year, 2 years
Secondary Outcome Measure Information:
Title
Disease Specific quality of life - Aberdeen Varicose Vein Questionnaire
Time Frame
1 week, 6 weeks, 3 months, 1 year, 2 years
Title
Generic quality of life - EuroQol
Time Frame
1 week, 6 weeks, 3 months, 1 year, 2 years
Title
Venous Clinical Severity Score
Time Frame
3 months, 1 year, 2 years
Title
Visual analogue pain scores
Time Frame
1 week
Title
Return to work and normal functioning
Time Frame
1 week, 6 weeks
Title
Would undergo EVLT again if necessary
Time Frame
1 week, 6 weeks, 3 months, 1 year, 2 years
Title
Complication rates
Time Frame
1 week, 6 weeks, 3 months, 1 year, 2 years
Title
Duplex and clinical assessment
Description
A detailed clinical and duplex ultrasound assessment was undertaken to identify: The presence of residual or recurrent varicose veins (defined as clinically evident varicose veins of greater than 3mm in diameter present at 1 and 6 weeks (residual) or becoming evident only after 6 weeks (recurrent). This was irrespective of the presence or absence of symptoms. The pattern of underlying insufficiency on duplex giving rise to any clinically evident varicose veins or skin changes.
Time Frame
1 week, 6 weeks, 3 months, 1 year, 2 years
Title
Cost Effectiveness
Time Frame
2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Primary, symptomatic, varicose veins. Isolated Saphenofemoral junction (SFJ) incompetence leading to long saphenous (LSV) reflux on duplex ultrasound. LSV of 4mm diameter at the knee. Ability to give informed written consent. Exclusion Criteria: Inability to give informed written consent. Symptomatic or complicated varicose veins not attributable to SFJ/LSV reflux. Evidence of deep venous reflux on duplex scan.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ian C Chetter, MBChB
Organizational Affiliation
University of Hull
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hull Royal Infirmary
City
Hull
State/Province
East Yorkshire
ZIP/Postal Code
HU3 2JZ
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
16802211
Citation
Mekako AI, Hatfield J, Bryce J, Lee D, McCollum PT, Chetter I. A nonrandomised controlled trial of endovenous laser therapy and surgery in the treatment of varicose veins. Ann Vasc Surg. 2006 Jul;20(4):451-7. doi: 10.1007/s10016-006-9095-y. Epub 2006 Jun 27.
Results Reference
background
PubMed Identifier
21638277
Citation
Carradice D, Mekako AI, Mazari FA, Samuel N, Hatfield J, Chetter IC. Clinical and technical outcomes from a randomized clinical trial of endovenous laser ablation compared with conventional surgery for great saphenous varicose veins. Br J Surg. 2011 Aug;98(8):1117-23. doi: 10.1002/bjs.7615. Epub 2011 Jun 3.
Results Reference
result
PubMed Identifier
21283981
Citation
Carradice D, Mekako AI, Mazari FA, Samuel N, Hatfield J, Chetter IC. Randomized clinical trial of endovenous laser ablation compared with conventional surgery for great saphenous varicose veins. Br J Surg. 2011 Apr;98(4):501-10. doi: 10.1002/bjs.7394. Epub 2011 Jan 31.
Results Reference
result
PubMed Identifier
30132797
Citation
Wallace T, El-Sheikha J, Nandhra S, Leung C, Mohamed A, Harwood A, Smith G, Carradice D, Chetter I. Long-term outcomes of endovenous laser ablation and conventional surgery for great saphenous varicose veins. Br J Surg. 2018 Dec;105(13):1759-1767. doi: 10.1002/bjs.10961. Epub 2018 Aug 22.
Results Reference
derived
PubMed Identifier
24424141
Citation
Carradice D, Wallace T, Gohil R, Chetter I. A comparison of the effectiveness of treating those with and without the complications of superficial venous insufficiency. Ann Surg. 2014 Aug;260(2):396-401. doi: 10.1097/SLA.0000000000000541.
Results Reference
derived
PubMed Identifier
20510634
Citation
Carradice D, Mazari FA, Mekako A, Hatfield J, Allgar V, Chetter IC. Energy delivery during 810 nm endovenous laser ablation of varicose veins and post-procedural morbidity. Eur J Vasc Endovasc Surg. 2010 Sep;40(3):393-8. doi: 10.1016/j.ejvs.2010.04.010. Epub 2010 May 26.
Results Reference
derived

Learn more about this trial

A New Method of Surgically Treating Varicose Veins and Venous Ulcers - a Study to Assess Clinical and Economic Value

We'll reach out to this number within 24 hrs